Phase
Condition
Warts
Hives (Urticaria)
Rash
Treatment
Topical and systemic drugs
Clinical Study ID
Ages < 99 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
dermatologist-diagnosed inflammatory skin disease
informed consent
Exclusion
Exclusion Criteria:
subject and/or the legal guardians are not able to give written informed consent
pregnant and breastfeeding women
concurrent participation in a clinical trial
use of systemic immunosuppressive therapy or phototherapy during the last 4 weeks orreceipt of biologics therapy (e.g. dupilumab, tralokinumab) within the last 3 months
treatment of the target skin areas with topical corticosteroids, calcineurininhibitors or emollients 24 hours before sample collection
Study Design
Study Description
Connect with a study center
Department of Dermatology and Allergy, University Hospital Schleswig-Holstein
Kiel, 24105
GermanyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.